Skip to content
etf.net

Launched · SEC filings

State Street SPDR S&P Health Care Equipment ETF

XHENYSE ArcaSPDRB

$92.58+1.43 (+1.56%)

As of Nov 2, 2026, 3:59 PM ET

B64/ 100

Rank 9 of 25 in Health Care (Broad)

B64/100Rank 9 of 25inHealth Care (Broad)
Intraday session: up, 79 prints from 91.16 to 92.58. Range 91.92 to 93.17. Use the arrow keys to read each point.91.5092.0093.0010 AM12 PM2 PM4 PM
Expense ratio
0.35%
Fund size
$157M
1Y total return
+14.3%
Yield · Last 12 months
0.02%
Holdings
75
Avg volume · 30D
29.7K sh
52W range
low $76.00high $97.65
Launched
Filings
SEC EDGAR

The ETF.net XHE Grade

Based on 5 of 6 pillars

B

Score 64 out of 100

Category
Health Care (Broad)⁠
Rank
9 of 25
Six-pillar profile for XHE. Scores out of 100: Cost 81, Risk 27, Mission not scored, Tradability 50, Holdings 93, Durability 68. Strongest: Holdings (93). Weakest: Risk (27). Based on 5 of 6 pillars.

Score 64 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    A81 out of 100
    Rank 5 of 25

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    D27 out of 100
    Rank 21 of 25

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    C50 out of 100
    Rank 12 of 25

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    A93 out of 100
    Rank 1 of 25

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    B68 out of 100
    Rank 9 of 25

Our read on XHE

ETF.net Research

In short

BHealth care minus the pharma giants. XHE holds a focused basket of US medical device and supply makers at near-equal weight, so a small stent company gets roughly the same shelf space as an industry titan.

Stated mandate

The fund seeks to match, before fees and expenses, the total return performance of the S&P Health Care Equipment Select Industry Index and provide exposure to the health care equipment segment of the S&P TMI.

Why people hold it

  • Modified equal weighting, reset on a quarterly schedule, keeps any one giant from dominating the basket. Small and mid-cap device names carry real weight here.ssga.comspglobal.com
  • 0.35% a year, below the median for health care ETFs in its peer group. Unusual for a slice this narrow, where issuers often charge up.
  • A true pure play: equipment and supplies drawn from the S&P Total Market Index. No pharma, no insurers, no hospital chains diluting the theme.ssga.com
  • Launched in 2011 by State Street, so this one has traded through more than a decade of device-sector cycles rather than arriving with the latest theme.

Worth knowing

  • Broad health care ETFs like VHT, FHLC and XLV charge a fraction of this. The targeted device basket is what the extra costs buy.
  • Thinly traded next to the big sector funds, so spreads can widen when markets move fast.
  • One sub-industry, tilted toward smaller companies, and SSGA notes the fund can become non-diversified purely from index weight shifts.ssga.com

XHE Holdings

Holdings pillarA93 out of 100Rank 1 of 25 in Health Care (Broad)
Asset class
Stocks
Holdings
75
Top-10 weight
18%
Largest holding
GKOS2.0%

Sectors

  • Health Care98.4%
  • Financials1.6%

Geography

  • United States100.00%
The fund’s holdings, weight-ordered — page 1 of 5.
#TickerCompanyWeight %SharesMarket valueHeld by ETFs
1GKOSGlaukos Corp2.04%13,216$3.2M131
2ISRGIntuitive Surgical Inc1.92%6,723$3.02M423
3ATECAlphatec Holdings Inc1.91%264,305$3.01M69
4ENOVEnovis Corp1.81%124,796$2.85M94
5ATRCAtricure Inc1.78%44,789$2.8M103
6GEHCGe Healthcare Technology1.77%36,437$2.78M308
7HAEHaemonetics Corp/Mass1.76%23,025$2.76M146
8RMDResmed Inc1.74%10,793$2.73M319
9SYKStryker Corp1.71%8,620$2.69M352
10IDXXIdexx Laboratories Inc1.69%4,609$2.65M360
11GMEDGlobus Medical Inc A1.68%31,876$2.64M160
12PODDInsulet Corp1.67%17,223$2.63M219
13BDXBecton Dickinson and Co1.67%13,215$2.62M205
14OMCLOmnicell Inc1.66%70,594$2.6M131
15EWEdwards Lifesciences Corp1.66%27,557$2.6M324

Showing 1–15 of 75 holdings

XHE Performance

Launched Jan 26, 2011

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

XHE$11,428
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. XHE $11,428. SPY $11,199. Use the arrow keys to read each point.$10,000$11,000$12,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for XHE. Periods over one year show the average yearly return.
PeriodXHE
Year to date+3.3%
1 month+0.5%
3 months+1.8%
1 year+14.3%
3 yearsper year+10.3%
5 yearsper year−6.2%
10 yearsper year+6.8%

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for XHE
YearReturn barXHE
2026 YTD+3.3%
2025−0.2%
2024+5.1%
2023−6.2%

XHE in the news

XHE Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 30, 2026.
0.02%Last 12 months
Payout per share
$0.02Last 12 months
Last payment
$0.02 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2017–2026

One bar per payment. 18 payments from 2017 to 2026 YTD. Jun 16, 2017 $0.0069; Sep 15, 2017 $0.00097; Dec 15, 2017 $0.49; Sep 24, 2018 $0.02; Dec 24, 2018 $0.05; Mar 18, 2019 $0.02; Jun 24, 2019 $0.02; Dec 23, 2019 $0.0032; Dec 20, 2021 $0.0019; Mar 21, 2022 $0.01; Sep 19, 2022 $0.01; Dec 19, 2022 $0.0066; Dec 18, 2023 $0.03; Sep 23, 2024 $0.007; Dec 23, 2024 $0.03; Jun 23, 2025 $0.02; Sep 22, 2025 $0.03; Dec 22, 2025 $0.02. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Dec 22, 2025Dec 24, 2025$0.02
Sep 22, 2025Sep 24, 2025$0.03
Jun 23, 2025Jun 25, 2025$0.02
Dec 23, 2024Dec 26, 2024$0.03
Sep 23, 2024Sep 25, 2024$0.007
Dec 18, 2023Dec 21, 2023$0.03
Dec 19, 2022Dec 22, 2022$0.0066
Sep 19, 2022Sep 22, 2022$0.01
Jun 21, 2022Jun 24, 2022No data
Mar 21, 2022Mar 24, 2022$0.01
Dec 20, 2021Dec 23, 2021$0.0019
Dec 23, 2019Dec 27, 2019$0.0032

See all 43 payments⁠

$10,000 in XHE 10 years ago paid $171 in dividends.⁠

XHE Risk

Risk pillarD27 out of 100Rank 21 of 25 in Health Care (Broad)
How much the fund’s monthly returns vary, scaled to a year.
19.6%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.37
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−49.4%
Trough Oct 2023
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
1.20
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

XHE Cost

Compare XHE and XLV

Overpaying vs XLV, cheapest in Health Care (Broad)

$5,437

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • XHE 0.35%

    $7,126

  • XLV 0.08% Cheapest

    $1,689

$10,000
30 years

Cost over time

  • XHE 0.35%
  • XLV 0.08%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$2K$4K$6K$8K051015202530XHE $7,126XLV $1,689

Year by year

YearXHEXLVOverpaying
10$634$147$487
20$2,454$575$1,879
30$7,126$1,689$5,437

Other funds in Health Care (Broad)

See others